{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:34Z","timestamp":1752105634750,"version":"3.41.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,9]]},"DOI":"10.7759\/cureus.87586","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T12:41:34Z","timestamp":1752064894000},"source":"Crossref","is-referenced-by-count":0,"title":["Eight-Year Survival Analysis of Patients With Dilated Cardiomyopathy: Does Treatment Era Affect Prognosis?"],"prefix":"10.7759","author":[{"given":"Lukas","family":"Kucera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Chud\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Dankov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Goncalvesov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-085081","article-title":"Demographic and clinical characteristics of New York City Health + Hospitals HIV Heart Failure (NYC4H cohort): cohort profile","volume":"14","author":"Chen YY","year":"2024","unstructured":"Chen YY, Borkowski P, Nazarenko N, et al.. Demographic and clinical characteristics of New York City Health + Hospitals HIV Heart Failure (NYC4H cohort): cohort profile. BMJ Open. 2024, 14:e085081. 10.1136\/bmjopen-2024-085081","journal-title":"BMJ Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovi\u0107 PM","year":"2019","unstructured":"Seferovi\u0107 PM, Polovina M, Bauersachs J, et al.. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019, 21:553-76. 10.1002\/ejhf.1461","journal-title":"Eur J Heart Fail"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad194","article-title":"ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo E","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, et al.. ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023, 44:3503-626.","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz908","article-title":"Dilated cardiomyopathy: so many cardiomyopathies!","volume":"41","author":"Sinagra G","year":"2020","unstructured":"Sinagra G, Elliott PM, Merlo M. Dilated cardiomyopathy: so many cardiomyopathies!. Eur Heart J. 2020, 41:3784-6.","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1714\/2140.23184","article-title":"Dilated cardiomyopathy: a dynamic disease - clinical course, reverse remodeling and prognostic stratification","volume":"17","author":"Merlo M","year":"2016","unstructured":"Merlo M, Gigli M, Poli S, et al.. Dilated cardiomyopathy: a dynamic disease - clinical course, reverse remodeling and prognostic stratification. G Ital Cardiol (Rome). 2016, 17:15-23. 10.1714\/2140.23184","journal-title":"G Ital Cardiol (Rome)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajmo.2023.100038","article-title":"Prevalence and clinical burden of idiopathic dilated cardiomyopathy in the United States","volume":"10","author":"Ababio Y","year":"2023","unstructured":"Ababio Y, Kelly SP, Angeli FS, et al.. Prevalence and clinical burden of idiopathic dilated cardiomyopathy in the United States. Am J Med Open. 2023, 10:100038. 10.1016\/j.ajmo.2023.100038","journal-title":"Am J Med Open"},{"key":"ref8","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, et al.. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:59497.","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59497","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:e59497. 10.7759\/cureus.59497","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh TA","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023, 44:3627-39.","journal-title":"Eur Heart J"},{"key":"ref11","article-title":"Manu\u00e1l diagnostick\u00fdch a lie\u010debn\u00fdch postupov","author":"Goncalvesov\u00e1 E","year":"2022","unstructured":"Goncalvesov\u00e1 E, Lesn\u00fd P, Lukn\u00e1r M, et al.. Manu\u00e1l diagnostick\u00fdch a lie\u010debn\u00fdch postupov. Herba, Bratislava, Slovakia; 2022."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.260","article-title":"Prognostic factors associated with 15-year mortality in patients with hospitalized systolic HF: results of the observational community-based EPICAL cohort study","volume":"228","author":"Agrinier N","year":"2017","unstructured":"Agrinier N, Thilly N, Brian\u00e7on S, et al.. Prognostic factors associated with 15-year mortality in patients with hospitalized systolic HF: results of the observational community-based EPICAL cohort study. Int J Cardiol. 2017, 228:940-7. 10.1016\/j.ijcard.2016.11.260","journal-title":"Int J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2022.05.003","article-title":"Fifteen-year mortality and prognostic factors in patients with dilated cardiomyopathy: persistent standardized application of drug therapy and strengthened management may bring about encouraging change in an aging society","volume":"19","author":"Xu XR","year":"2022","unstructured":"Xu XR, Han MM, Yang YZ, et al.. Fifteen-year mortality and prognostic factors in patients with dilated cardiomyopathy: persistent standardized application of drug therapy and strengthened management may bring about encouraging change in an aging society. J Geriatr Cardiol. 2022, 19:335-42. 10.11909\/j.issn.1671-5411.2022.05.003","journal-title":"J Geriatr Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12548","article-title":"Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy","volume":"7","author":"Briongos-Figuero S","year":"2020","unstructured":"Briongos-Figuero S, Est\u00e9vez A, P\u00e9rez ML, et al.. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy. ESC Heart Fail. 2020, 7:279-83. 10.1002\/ehf2.12548","journal-title":"ESC Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014240","article-title":"Clinical implications of the New York Heart Association classification","volume":"8","author":"Caraballo C","year":"2019","unstructured":"Caraballo C, Desai NR, Mulder H, et al.. Clinical implications of the New York Heart Association classification. J Am Heart Assoc. 2019, 8:e014240. 10.1161\/JAHA.119.014240","journal-title":"J Am Heart Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082426","article-title":"Sex-specific prognostic implications in dilated cardiomyopathy after left ventricular reverse remodeling","volume":"9","author":"Cannata A","year":"2020","unstructured":"Cannata A, Manca P, Nuzzi V, et al.. Sex-specific prognostic implications in dilated cardiomyopathy after left ventricular reverse remodeling. J Clin Med. 2020, 9:26. 10.3390\/jcm9082426","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1914","article-title":"Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy","volume":"22","author":"Merlo M","year":"2020","unstructured":"Merlo M, Cannat\u00e0 A, Pio Loco C, et al.. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2020, 22:1111-21. 10.1002\/ejhf.1914","journal-title":"Eur J Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000120","article-title":"Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management","volume":"6","author":"Castelli G","year":"2013","unstructured":"Castelli G, Fornaro A, Ciaccheri M, et al.. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management. Circ Heart Fail. 2013, 6:913-21. 10.1161\/CIRCHEARTFAILURE.112.000120","journal-title":"Circ Heart Fail"},{"key":"ref20","article-title":"The variable natural history of idiopathic dilated cardiomyopathy","volume":"14","author":"Parakh K","year":"2012","unstructured":"Parakh K, Kittleson MM, Heidecker B, et al.. The variable natural history of idiopathic dilated cardiomyopathy. Isr Med Assoc J. 2012, 14:666-71.","journal-title":"Isr Med Assoc J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah S","year":"2002","unstructured":"Kenchaiah S, Evans JC, Levy D, et al.. Obesity and the risk of heart failure. N Engl J Med. 2002, 347:305-13. 10.1056\/NEJMoa020245","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1049936","article-title":"Ferroptosis increases obesity: crosstalk between adipocytes and the neuroimmune system","volume":"13","author":"Zhang S","year":"2022","unstructured":"Zhang S, Sun Z, Jiang X, et al.. Ferroptosis increases obesity: crosstalk between adipocytes and the neuroimmune system. Front Immunol. 2022, 13:1049936. 10.3389\/fimmu.2022.1049936","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2007.02.083","article-title":"N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm","volume":"16","author":"Tigen K","year":"2007","unstructured":"Tigen K, Karaahmet T, Kahveci G, et al.. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm. Heart Lung Circ. 2007, 16:290-4. 10.1016\/j.hlc.2007.02.083","journal-title":"Heart Lung Circ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047019","article-title":"Temporal trends in prevalence and prognostic implications of comorbidities among patients with acute decompensated heart failure: the ARIC study community surveillance","volume":"142","author":"Pandey A","year":"2020","unstructured":"Pandey A, Vaduganathan M, Arora S, et al.. Temporal trends in prevalence and prognostic implications of comorbidities among patients with acute decompensated heart failure: the ARIC study community surveillance. Circulation. 2020, 142:230-43. 10.1161\/CIRCULATIONAHA.120.047019","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14916","article-title":"Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes","volume":"25","author":"Wu MZ","year":"2023","unstructured":"Wu MZ, Teng TK, Tay WT, et al.. Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes. Diabetes Obes Metab. 2023, 25:707-15. 10.1111\/dom.14916","journal-title":"Diabetes Obes Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.05.015","article-title":"Cardio-renal-metabolic overlap, outcomes, and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"11","author":"Ostrominski JW","year":"2023","unstructured":"Ostrominski JW, Thierer J, Claggett BL, et al.. Cardio-renal-metabolic overlap, outcomes, and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. JACC Heart Fail. 2023, 11:1491-503. 10.1016\/j.jchf.2023.05.015","journal-title":"JACC Heart Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene SJ","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM, et al.. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry. J Am Coll Cardiol. 2018, 72:351-66. 10.1016\/j.jacc.2018.04.070","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002744","article-title":"Influence of ejection fraction on outcomes and efficacy of sacubitril\/valsartan (LCZ696) in heart failure with reduced ejection fraction: the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure (PARADIGM-HF) trial","volume":"9","author":"Solomon SD","year":"2016","unstructured":"Solomon SD, Claggett B, Desai AS, et al.. Influence of ejection fraction on outcomes and efficacy of sacubitril\/valsartan (LCZ696) in heart failure with reduced ejection fraction: the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure (PARADIGM-HF) trial. Circ Heart Fail. 2016, 9:e002744. 10.1161\/CIRCHEARTFAILURE.115.002744","journal-title":"Circ Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383878-eight-year-survival-analysis-of-patients-with-dilated-cardiomyopathy-does-treatment-era-affect-prognosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T12:41:36Z","timestamp":1752064896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383878-eight-year-survival-analysis-of-patients-with-dilated-cardiomyopathy-does-treatment-era-affect-prognosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.87586","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}